Study: GLP-1 drugs like semaglutide linked to lower amputation risk in diabetes patients with peripheral artery disease
By
Peter Morales-Brown
Summary
A new study suggests that GLP-1 receptor agonists (like Ozempic and Wegovy) are associated with better outcomes in people with type 2 diabetes and peripheral artery disease (PAD) compared to metformin. Patients taking GLP-1 medications required fewer procedures to restore blood flow to blocked leg arteries, indicating the drugs may slow PAD progression. The benefits were most pronounced in those with severe PAD at highest risk of amputation.
Source
Twitter / XStudy: GLP-1 drugs like semaglutide linked to lower amputation risk in diabetes patients with peripheral artery diseasemedicalnewstoday.comKey quotes
· 3 pulledA new study suggests GLP-1 receptor agonists, such as Ozempic and Wegovy, are associated with better overall outcomes in people with type 2 diabetes and peripheral artery disease (PAD), compared with metformin.
Those taking GLP-1 medications also required fewer procedures to restore blood flow to blocked leg arteries, suggesting the drugs may help slow the progression of PAD.
The greatest benefits were seen in people with severe PAD, including those at highest risk of amputation.
You might also wanna read
Semaglutide Shows Chondroprotective Effects in Osteoarthritis Through Weight Loss-Independent Metabolic Mechanism
This research article demonstrates that semaglutide, a GLP-1 receptor agonist, provides chondroprotective effects in osteoarthritis mouse mo
Study Finds GLP-1 Drugs Associated with 58% Lower Mortality in Colon Cancer Patients
A study analyzing over 6,800 colon cancer patients across University of California Health sites found that patients taking GLP-1 medications
Wegovy's Canadian Launch and AI's Role in Accelerating Weight Drug Discovery
The article discusses the shifting metabolic health landscape, highlighting obesity as a complex disease and the launch of Wegovy in Canada
startuphub.ai·8d ago
Study Finds GLP-1 Drug Users Show Decreased Physical Activity Levels
A new study presented by doctors at HSHS Saint John's Hospital in Illinois found that people taking GLP-1 drugs like Ozempic and Wegovy sign
gizmodo.com·23d ago
GLP-1 Prescriptions Rise as U.S. Obesity Rates Show Modest Decline, New Data Indicates
New data from EPIC Research shows that GLP-1 medications like Ozempic and Wegovy are having a population-wide impact on obesity rates. As pr
gizmodo.com·1mo ago
AI Analysis of Reddit Posts Identifies Potential Side Effects of GLP-1 Weight Loss Drugs
Researchers at the University of Pennsylvania used AI to analyze over 410,000 Reddit posts spanning six years to identify potential side eff
sciencealert.com·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.